Work

Lenalidomide and Rituximab Are a Promising Combination in Vitro, in Vivo Preclinically and in a Phase I/II Clinical Trial in Relapsed/Refractory Mantle Cell Lymphoma

Year: 2008

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v112.11.3058.3058

Authors: Michael Wang, Liang Zhang, Luis Fayad, Fredrick Hagemeister, Sattva Neelapu, Felipe Samaniego, Barbara Pro, Anas Younes, Scott Miller, Robert D. Knight, Jerome B. Zeldis, Qing Yi, Jorge Romaguera

Institutions: The University of Texas MD Anderson Cancer Center, Celgene (United States)

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2531097482

FWCI: 0.211

Cites:

Cited by: 2

Related to: 10